STOCK TITAN

Varex Imaging Corp - VREX STOCK NEWS

Welcome to our dedicated news page for Varex Imaging (Ticker: VREX), a resource for investors and traders seeking the latest updates and insights on Varex Imaging.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Varex Imaging's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Varex Imaging's position in the market.

Rhea-AI Summary
Varex Imaging (Nasdaq: VREX) has scheduled the release of its unaudited financial results for the second quarter of fiscal year 2024 on May 2, 2024, after the close of regular trading. A conference call will follow at 3:00 pm Mountain Time, which can be accessed via webcast on the company's website. Investors in the U.S. can also dial in at 877-524-8416, and those outside the U.S. can call 412-902-1028. The webcast will be archived on the website, with a replay available until May 16th at 877-660-6853 or 201-612-7415.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Varex Imaging (VREX) has secured a senior secured revolving credit agreement worth up to $155 million. The agreement aims to enhance liquidity for working capital and general corporate purposes, potentially aiding in debt repayment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.67%
Tags
none
-
Rhea-AI Summary
Varex Imaging Corporation (VREX) to present at Oppenheimer Healthcare MedTech & Services Virtual Conference. The management will participate in a fireside chat on March 12, 2024, at 1:20pm EDT. Webcast available on Varex's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.46%
Tags
conferences
Rhea-AI Summary
Varex Imaging Corporation (VREX) reported unaudited financial results for the first quarter of fiscal year 2024, with revenues of $190 million, representing a 8% year-over-year decrease. The GAAP gross margin was 30%, while the non-GAAP gross margin was 31%. The GAAP operating margin was 2%, and the non-GAAP operating margin was 5%. The company reported a GAAP net loss of $0.01 per diluted share and a non-GAAP net earnings of $0.06 per diluted share. Cash flow from operations was $10 million, and the balance sheet showed stable working capital management with flat cash, cash equivalents, marketable securities, and CDs at $195 million. Varex provided guidance for the second quarter of fiscal year 2024, expecting revenues between $195 million and $215 million, and non-GAAP net earnings per diluted share between $0.10 and $0.30.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.21%
Tags
-
Rhea-AI Summary
Varex Imaging Corporation (VREX) will report unaudited financial results for Q1 of fiscal year 2024 on February 6, 2024, followed by a conference call. The webcast and replay details are available on the company's website. Investors can access the call from the U.S. and non-U.S. locations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.1%
Tags
-
Rhea-AI Summary
Varex Imaging Corporation (VREX) to Present at CJS Securities 24th Annual New Ideas for the New Year Virtual Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.34%
Tags
conferences
Rhea-AI Summary
Varex Imaging Corporation (Nasdaq: VREX) to participate in two investor conferences, including the 6th Annual Evercore ISI HealthCONx Conference and Mizuho Medical Devices & Healthcare Services Summit 2023. Details available on Varex's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.39%
Tags
conferences
-
Rhea-AI Summary
Varex Imaging Corporation (Nasdaq: VREX) announced unaudited financial results for Q4 FY23, reporting $227M in revenues, GAAP gross margin of 34%, Non-GAAP gross margin of 36%, and more. The company's revenues decreased 2% sequentially from Q3 FY23, with Medical segment down 7% and Industrial segment up 12%. Cash flow from operations was $47M for Q4 FY23. The company provided guidance for Q1 FY24 with revenues expected between $180M and $200M and Non-GAAP net income per diluted share expected between $0.00 and $0.20.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.82%
Tags
-
Rhea-AI Summary
Varex Imaging Corporation will report unaudited financial results for Q4 and full fiscal year 2023 on November 14, 2023. A conference call will follow at 3:00 pm MT. Webcast and replay details provided.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.7%
Tags
Rhea-AI Summary
Varex Imaging to present at Sidoti Small Cap Virtual Conference on September 20, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.16%
Tags
conferences
Varex Imaging Corp

Nasdaq:VREX

VREX Rankings

VREX Stock Data

700.67M
40.18M
4.91%
110.18%
11.29%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Salt Lake City

About VREX

our mission: to be the world’s leader in imaging components through the delivery of high-quality products that enables our customers’ success. our vision: to create the most innovative and cost-effective x-ray imaging solutions for equipment manufacturers. varex imaging corporation is the world’s largest independent supplier of medical x-ray tubes and image processing solutions. from medical imaging to cargo screening and border security, our components are used by x-ray imaging system manufacturers everywhere to detect, diagnose, and protect. our products are designed to harness the power of x-ray energy to pioneer advances in any application. this requires us to maintain an extensive catalog, and we are a leading supplier of high-voltage connectors, x-ray collimators, ionization chambers, mammography paddles, solid state automatic exposure control systems and buckies for digital imaging. as a leader in imaging components, our goal is to help our customers become world-class system su